SZSE:002773 (China)
Â
Class A
Â¥
21.40
(-0.23%)
Jul 16
Business Description
Chengdu Kanghong Pharmaceutical Group Co Ltd
ISIN : CNE1000020C4
Share Class Description:
SZSE:002773: Class ACompare
Compare
Traded in other countries / regions
002773.China IPO Date
2015-06-26Description
Chengdu Kanghong Pharmaceutical Group Co Ltd is a pharmaceutical company. The company is engaged in the research and development, production, and sales of medicine, chemical medicine, and biological products.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2630.52 | |||||
Equity-to-Asset | 0.93 | |||||
Interest Coverage | 12.3 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 21.58 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.5 | |||||
3-Year Book Growth Rate | 10.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.96 | |||||
9-Day RSI | 42.78 | |||||
14-Day RSI | 45.07 | |||||
6-1 Month Momentum % | 27.72 | |||||
12-1 Month Momentum % | 17.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.58 | |||||
Quick Ratio | 8.91 | |||||
Cash Ratio | 8.52 | |||||
Days Inventory | 307.23 | |||||
Days Sales Outstanding | 16.05 | |||||
Days Payable | 256.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.77 | |||||
Dividend Payout Ratio | 0.12 | |||||
3-Year Dividend Growth Rate | -18.8 | |||||
Forward Dividend Yield % | 1.77 | |||||
5-Year Yield-on-Cost % | 0.85 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 1.7 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 89.21 | |||||
Operating Margin % | 30.54 | |||||
Net Margin % | 27.34 | |||||
FCF Margin % | 31.22 | |||||
ROE % | 14.97 | |||||
ROA % | 13.67 | |||||
ROIC % | 31.67 | |||||
ROC (Joel Greenblatt) % | 52.09 | |||||
ROCE % | 16.54 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.12 | |||||
PE Ratio without NRI | 17.13 | |||||
Shiller PE Ratio | 31.94 | |||||
Price-to-Owner-Earnings | 28.08 | |||||
PS Ratio | 4.67 | |||||
PB Ratio | 2.41 | |||||
Price-to-Tangible-Book | 2.53 | |||||
Price-to-Free-Cash-Flow | 15 | |||||
Price-to-Operating-Cash-Flow | 13.58 | |||||
EV-to-EBIT | 11.52 | |||||
EV-to-EBITDA | 11.52 | |||||
EV-to-Revenue | 3.52 | |||||
EV-to-FCF | 12.04 | |||||
Price-to-Projected-FCF | 2.28 | |||||
Price-to-Graham-Number | 1.39 | |||||
Price-to-Net-Current-Asset-Value | 3.91 | |||||
Price-to-Net-Cash | 4.47 | |||||
Earnings Yield (Greenblatt) % | 8.68 | |||||
FCF Yield % | 6.61 | |||||
Forward Rate of Return (Yacktman) % | 12.46 |